Pilot Study of Percutaneous Correction of Hallux Valgus
This is a pilot study with a randomized controlled design.
| Condition(s) | Hallux Valgus |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This is a pilot study with a randomized controlled design. |
| Who can participate | Inclusion Criteria: * Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment * HVA (hallux valgus angle): 20°-40° * IMA (intermetatarsal angle): 10°-20° Exclusion Criteria: * Patients with instability of the first metatarsophalangeal joint * Patients with severe morphostructural alterations or other pathologies in the foot and lower limb * patients requiring additional surgical procedures * patients with severe vascular and neurological systemic pathologies * systemic pathologies that may impair bone consolidation |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | Istituto Ortopedico Rizzoli |
| Locations | Bologna, Italy |
| Start date | 2022-02-22 |
| NCT ID | NCT05880407 |
| Official listing | https://clinicaltrials.gov/study/NCT05880407 |